Contrast-induced nephropathy (CIN) represents an important adverse effect of contrast
media (CM) administration. Contrast-induced nephropathy is associated with prolonged …

Contrast-induced nephropathy (CIN) is a serious, but potentially preventable adverse event
associated with the use of iodinated contrast media (CM). Studies suggest that the …

Recent improvements in contrast agents and radiologic imaging tools have resulted in an
increasing number of patients undergoing contrast media (CM)-enhanced examinations …

With the advances made in radiology and cardiology, greater numbers of patients are
expected to undergo exposure to iodinated contrast media in the years to come. Contrast …

Contrast-induced nephropathy (CIN) is associated with increased morbidity and mortality, as
well as increased costs for medical care, particularly in patients with diabetes mellitus and …

Use of iodinated contrast media for diagnostic and interventional procedures is increasing
as computed tomography and percutaneous coronary intervention (PCI) technologies …

Contrast-induced nephropathy (CIN) is a serious complication of angiographic procedures
resulting from the administration of contrast media (CM). It is the third most common cause of …

Contrast induced nephropathy (CIN) is an iatrogenic disorder, resulting from exposure to
contrast media. Contrast‐induced hemodynamic and direct cytotoxic effects on renal …

Contrast-induced nephropathy (CIN) is one of the most serious adverse events associated
with the use of contrast media (CM). Patients who develop this complication can have …

Contrast-induced nephropathy (CIN) has long been observed in both experimental and
clinical studies. However, recent observational studies have questioned the prevalence and …